Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    edited by Susan M. DeNisco, Anne M. Barker.
    Summary: "Advanced Practice Nursing: Essential Knowledge for the Profession, Third Edition is a core advanced practice text used in both Master's Level and DNP programs. The Third Edition is a unique compilation of existing chapters from a variety of high-level Jones & Bartlett Learning works creating a comprehensive and well-rounded resource for the advanced practice nursing student. Similar to the previous edition, The Third Edition is framed around the AACN's Master's Essentials as well as the Essentials for Doctoral Education featuring the most up-to-date content on each set of Essentials. Throughout the Third Edition the authors address the rapid changes in the health care environment with a special focus on health care finance, electronic health records, quality and safety as well as emerging roles for the advanced practice nurse. Patient care in the context of the advanced nursing role is also discussed."--Publisher's website.

    Contents:
    Professional roles for the advanced practice nurse
    Healthcare delivery and health policy for advanced practice : core knowledge
    Quality, safety, and information systems for advanced practice nurses
    Theoretical foundations, research, and evidence-based practice
    The role of race, culture, ethics, and advocacy in advanced nursing practice
    Leadership and role transition for the advanced practice nurse.
    Digital Access R2Library 2016
    Limited to 1 simultaneous user
  • Book
    by Hubert Pfeiffer, Thomas Klupsch, Werner Haubenreisser.
    Print 1989
  • Article
    Wong PP, Yagoda A.
    Cancer. 1978 Apr;41(4):1256-60.
    Thirty-nine chemotherapy trials in 16 patients with metastatic hemangiopericytoma treated at MSKCC and 33 trials from the literature are reviewed. Adriamycin, alone or in combination drug regimens, is the most effective agent, producing complete and partial remission in 50% of cases. Other drugs which show some activity include vincristine, cyclophosphamide, actinomycin, methotrexate and DTIC. The available data indicate malignant hemangiopericytoma should be considered chemotherapeutically responsive tumors.
    Digital Access Access Options